Discovery & Exploratory Clinical Research
Research and development is the heart and soul of Bristol-Myers Squibb. The Discovery and Exploratory Clinical Research group represents the beginning of that process. Our goal is to discover drugs and conduct early stage clinical studies to show the value of those drugs, evaluate their safety and determine how they work.
We discover new drugs, both large and small molecules, by first focusing on serious diseases in our six therapeutic areas: cancer, immunology, metabolics, cardiovascular, virology and neuroscience. We find biological targets that we think have some effect on serious disease. Then we look for ways to influence that target and change the pathological process.
Our early development group then works to confirm that we can deliver on the promise of this new drug in a way that is safe and effective for patients. All of this takes years.
“We in the Discovery and Exploratory Clinical Research group believe that by working together at Bristol-Myers Squibb, we can effect a much bigger impact on the world of patient care than we could working alone in other fields,” says Francis Cuss, M.D., F.R.C.P., senior vice president, Discovery and Exploratory Clinical Research.
As ground-breaking science and external market factors continue to evolve, innovation will play an increasingly critical role in maintaining competitive advantage. In Discovery, we continuously strive for innovation not only in our pipeline but also in our processes; we focus on how we can deliver value to the patient. For example, we evaluate the use of technology to improve the speed and efficiency of our business practices, operations, and transitions of potential drugs to development. We also look to reduce cycle time by conducting only essential studies early in the development phase.
Committed biologists, chemists, engineers and medical doctors who demonstrate intelligence, enormous curiosity and the ability to question the status quo will feel welcome here. Those with a willingness to be open to change and to partner across diverse teams with colleagues of different scientific, ethnic, gender and cultural backgrounds will find our collaborative environment refreshing.